ARCHIVES

Local Labs Not As Accurate As Central Testing For HER2

This article is from The Cancer Letter archive.

Vol. 25 No. 8 | August 30, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

ACOR Opens Cancer-pain.org

March 2, 2001

Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods

August 12, 1977

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980